Deepinder Goyal, the founder of Zomato, has a new startup. It's called Temple — a wearable that tracks blood flow in your brain. His theory is that improving that flow could slow down aging. Doctors aren't convinced. Investors seem to be.
Temple is valued at 190 million dollars. The science behind it hasn't been peer reviewed. And India has a rapidly aging population that could genuinely use some answers.
So who exactly is this for?
Tune in.
Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.
